Literature DB >> 526925

Role of cholesterol in enhancing the antitumor activity of cytosine arabinoside entrapped in liposomes.

E Mayhew, Y M Rustum, F Szoka, D Papahadjopoulos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 526925

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  13 in total

1.  Engineering targeted in vivo drug delivery. I. The physiological and physicochemical principles governing opportunities and limitations.

Authors:  C A Hunt; R D Macgregor; R A Siegel
Journal:  Pharm Res       Date:  1986-12       Impact factor: 4.200

2.  Anti-tumor activity of liposome encapsulated fluoroorotic acid as a single agent and in combination with liposome irinotecan.

Authors:  Kareen Riviere; Heidi M Kieler-Ferguson; Katherine Jerger; Francis C Szoka
Journal:  J Control Release       Date:  2011-05-07       Impact factor: 9.776

3.  Sterol-modified phospholipids: cholesterol and phospholipid chimeras with improved biomembrane properties.

Authors:  Zhaohua Huang; Francis C Szoka
Journal:  J Am Chem Soc       Date:  2008-10-25       Impact factor: 15.419

4.  Pharmacokinetics and tissue distribution of liposome-encapsulated cis-bis-N-decyl-iminodiacetato-1,2-diaminocyclohexane-platinum (II).

Authors:  J Lautersztain; R Perez-Soler; A R Khokhar; R A Newman; G Lopez-Berestein
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

Review 5.  Lipid-based nanotherapeutics for siRNA delivery.

Authors:  A Schroeder; C G Levins; C Cortez; R Langer; D G Anderson
Journal:  J Intern Med       Date:  2010-01       Impact factor: 8.989

6.  Modulation of the peritoneal clearance of liposomal cytosine arabinoside by blank liposomes.

Authors:  S Kim; D J Kim; S B Howell
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

Review 7.  Liposomes as carriers of cancer chemotherapy. Current status and future prospects.

Authors:  S Kim
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

8.  Thermosensitive sterically stabilized liposomes: formulation and in vitro studies on mechanism of doxorubicin release by bovine serum and human plasma.

Authors:  M H Gaber; K Hong; S K Huang; D Papahadjopoulos
Journal:  Pharm Res       Date:  1995-10       Impact factor: 4.200

9.  Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors.

Authors:  A Gabizon; D Papahadjopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

10.  Altered pharmacological properties of liposome-associated human interferon-alpha.

Authors:  D A Eppstein; W E Stewart
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.